Information Provided By: 
Fly News Breaks for September 21, 2017
ALNY
Sep 21, 2017 | 08:18 EDT
Credit Suisse analyst Alethia Young raised her price target for Alnylam to $123 from $96 as she thinks porphyria data in mid-2018 and patisiran's expansion into the cardiac subtype can continue to drive upside from here. The analyst reiterates an Outperform rating on the shares.
News For ALNY From the Last 2 Days
ALNY
Apr 23, 2024 | 07:17 EDT
ProQR Therapeutics (PRQR) announced the Annual General Meeting, AGM, of Shareholders will take place on Wednesday, May 22, 2024 at the offices of Allen & Overy LLP, in Amsterdam, the Netherlands. As part of the AGM, Martin Maier, PhD, is nominated for appointment as a non-executive Board Member for a period of four years. Dr. Maier is Senior Vice President Research heading the Oncology group at Alnylam Pharmaceuticals (ALNY).
